Valiant Laboratories' board has approved the audited financial results for the quarter ended June 30, 2026. Consolidated Revenue hit ₹115.29 Cr, with Net Profit at ₹21.10 Cr.

Valiant Laboratories LimitedVALIANTLAB · Filed with the exchange

EPS for the quarter stands at ₹3.89.

No comments yet. Be the first.

More from Valiant Laboratories Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.